Submental Area Treatment with ATX-101: Relationship of Mechanism of Action, Tissue Response, and Efficacy by Shannon Humphrey, MD, FRCPC, FAAD, Girish S. Munavalli, MD, MHS, FACMS, Steven G. Yoelin, MD, Daniel P. Friedmann, MD, FAAD, Carmen M. Kavali, MD, Sara Sangha, PhD

Get full text

OnabotulinumtoxinA Treatment for Moderate to Severe Forehead Lines: A Review by Koenraad De Boulle, MD, Alastair Carruthers, MD, Nowell Solish, MD, Jean Carruthers, MD, Wolfgang G. Philipp-Dormston, MD, Steven Fagien, MD, Sara Sangha, PhD, Michael Silberberg, MD, MBA, Cheri Mao, MS

Get full text

Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations by Craig F. Teller, MD, Annie Chiu, MD, Cameron D. Chesnut, MD, Deborah Sherman, MD, José Raul Montes, MD, Sara Gaspard, MD, Terrence Keaney, MD, Neil S. Sadick, MD, Steve Yoelin, MD, Sara Sangha, PhD, Sachin M. Shridharani, MD

Get full text